Johnson & Johnson to Host Medical Devices & Diagnostics Review

NEW BRUNSWICK, N.J., Oct. 25, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a Medical Devices & Diagnostics business review for the investment community beginning at 8:30 a.m. (Eastern Time) on Thursday, November 1st at the Hyatt Regency Hotel in New Brunswick, N.J.

The program will include presentations by Johnson & Johnson's senior management representing our Medical Devices & Diagnostics segments.  Dominic Caruso, Vice President, Finance and Chief Financial Officer will open the meeting.  

A live webcast will be available through www.investor.jnj.com.  This webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads.  A replay and podcast will be available approximately two hours after the meeting concludes.

SOURCE Johnson & Johnson

Suggested Articles

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.

Bluebird has priced gene therapy Zynteglo at €1.575 million in Europe and promised a U.S. price in “reasonably close” range.

Generic pain drug maker Lannett is closing its plant in Wyoming and laying off the remaining 80 employees.